Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Considerations in the development of circulating tumor cell technology for clinical use.
Parkinson DR, Dracopoli N, Petty BG, Compton C, Cristofanilli M, Deisseroth A, Hayes DF, Kapke G, Kumar P, Lee JSh, Liu MC, McCormack R, Mikulski S, Nagahara L, Pantel K, Pearson-White S, Punnoose EA, Roadcap LT, Schade AE, Scher HI, Sigman CC, Kelloff GJ. Parkinson DR, et al. J Transl Med. 2012 Jul 2;10:138. doi: 10.1186/1479-5876-10-138. J Transl Med. 2012. PMID: 22747748 Free PMC article. Review.
Reanalysis of cancer drugs: old drugs, new tricks.
Vande Woude GF, Kelloff GJ, Ruddon RW, Koo HM, Sigman CC, Barrett JC, Day RW, Dicker AP, Kerbel RS, Parkinson DR, Slichenmyer WJ. Vande Woude GF, et al. Among authors: parkinson dr. Clin Cancer Res. 2004 Jun 1;10(11):3897-907. doi: 10.1158/1078-0432.CCR-03-0786. Clin Cancer Res. 2004. PMID: 15173099 Review. No abstract available.
Strategy and planning for chemopreventive drug development: clinical development plans II.
Kelloff GJ, Crowell JA, Hawk ET, Steele VE, Lubet RA, Boone CW, Covey JM, Doody LA, Omenn GS, Greenwald P, Hong WK, Parkinson DR, Bagheri D, Baxter GT, Blunden M, Doeltz MK, Eisenhauer KM, Johnson K, Knapp GG, Longfellow DG, Malone WF, Nayfield SG, Seifried HE, Swall LM, Sigman CC. Kelloff GJ, et al. Among authors: parkinson dr. J Cell Biochem Suppl. 1996;26:54-71. doi: 10.1002/jcb.240630705. J Cell Biochem Suppl. 1996. PMID: 9154168
Clinical and immunomodulatory effects of combination immunotherapy with low-dose interleukin 2 and tumor necrosis factor alpha in patients with advanced non-small cell lung cancer: a phase I trial.
Yang SC, Grimm EA, Parkinson DR, Carinhas J, Fry KD, Mendiguren-Rodriguez A, Licciardello J, Owen-Schaub LB, Hong WK, Roth JA. Yang SC, et al. Among authors: parkinson dr. Cancer Res. 1991 Jul 15;51(14):3669-76. Cancer Res. 1991. PMID: 1648441 Clinical Trial.
117 results